Skip to content
Plain Review

Giving Stem Cells During Pregnancy to Babies with Neural Tube Defect Improves Life Outcomes, Research Shows

A groundbreaking research effort has revealed that providing pluripotent cells to developing infants affected by spina bifida while undergoing fetal surgery can be a "important advancement" in addressing congenital conditions.

Trial Details and Safety

The US-based trial involved six unborn babies with a severe neural tube defect. Surgeons applied regenerative cells sourced from the maternal placenta directly onto the baby's spinal cord as part of the surgical correction.

Critically, the cell therapy proved to be secure. Doctors verified that the therapy did not induce cancerous growths, hinder surgical recovery, or block the correction of associated brain abnormalities.

Promising Outcomes

Imaging conducted after delivery confirmed a complete reversal of Chiari malformation in every participant. This favorable anatomical change is closely linked to enhanced physical outcomes.

"In the event it allows more children able to walk who previously could not, then it would become their standard of care," commented the principal investigator. "The results are profoundly encouraging and open the door to a variety of prospective new treatments."

Broader Impact and Encouragement

Commentators reviewing the findings indicated that additional validation of these apparent benefits could signal a "new era" in fetal surgery. The potential to improve nerve function impairment seen in utero is regarded as a transformative goal.

Notably important would be better management of urogenital and gastrointestinal outcomes, which are common challenges for those diagnosed with this defect.

Future Directions

While this initial trial was small in scale, its established security and encouraging indicators provide a strong foundation for expanded clinical research. The integration of stem cell therapy with proven prenatal surgical methods offers substantial hope for improving the prognosis for babies yet to be born with this neural tube defect.

About the author

Christopher Robinson

Maya is a tech journalist and entrepreneur with over a decade of experience covering digital innovations and startup culture.

Plain Review

Type to search articles.